Trial
NCT01150409
Hemodynamic and Inflammatory Effects of Abrupt Versus Tapered Corticosteroid Discontinuation in Septic Shock
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The Cleveland Clinic
Collaborators
—
Condition
Septic Shock
Intervention
hydrocortisone
Why stopped
Difficulty in recruiting eligible subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-02